Efficacy and safety of albiglutide, a once-weekly glucagon-like peptide-1 receptor agonist, in patients with type 2 diabetes: a systematic review and meta-analysis
Nausea, vomiting, and diarrhea are commonly reported, particularly during dose escalation, with rates varying by product and dose
High cortisol can raise insulin and increase belly fat storage
Body composition (NMR, Bruker Optics) was measured prior to vehicle/Glp1r agonist treatment, after the last day of treatment, and at day 6-7 following cessation of treatment
FIGURE 2 The first part of the third alcohol drinking experiment aimed to confirm previous studies in which exposure to HFD reduces alcohol drinking in male rats (Sirohi et al., 2017a